Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vermeire

Showing results (121-130 of 137) with videos related to

Pageof 14
Sort By:
Gut|June 29, 2011
Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitisL Márquez, C Shen, I Cleynen, et al.
The British Journal of Surgery|July 27, 2017
Short- and medium-term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centresA de Buck van Overstraeten, E J Eshuis, S Vermeire, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2015
Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's diseaseB G Feagan, W J Sandborn, G D'Haens, et al.
Gut|February 17, 2006
European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosisE F Stange, S P L Travis, S Vermeire, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2009
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodiesM Allez, S Vermeire, N Mozziconacci, et al.
Revista De Gastroenterologia De Mexico|March 15, 2015
[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Spanish version)]A Dignass, J O Lindsay, A Sturm, et al.
Clinical and Experimental Immunology|August 25, 2010
Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitisI J J Claes, Sarah Lebeer, C Shen, et al.
Journal of Crohn'S & Colitis|December 22, 2010
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosisE F Stange, S P L Travis, S Vermeire, et al.
Gut|September 10, 2005
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohortF L Wolters, M G Russel, J Sijbrandij, et al.
Digestion|June 30, 2007
Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up studyK H Katsanos, S Vermeire, D K Christodoulou, et al.
Pageof 14

Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Gut|June 29, 2011
Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitisL Márquez, C Shen, I Cleynen, et al.
The British Journal of Surgery|July 27, 2017
Short- and medium-term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centresA de Buck van Overstraeten, E J Eshuis, S Vermeire, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2015
Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's diseaseB G Feagan, W J Sandborn, G D'Haens, et al.
Gut|February 17, 2006
European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosisE F Stange, S P L Travis, S Vermeire, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2009
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodiesM Allez, S Vermeire, N Mozziconacci, et al.
Revista De Gastroenterologia De Mexico|March 15, 2015
[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Spanish version)]A Dignass, J O Lindsay, A Sturm, et al.
Clinical and Experimental Immunology|August 25, 2010
Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitisI J J Claes, Sarah Lebeer, C Shen, et al.
Journal of Crohn'S & Colitis|December 22, 2010
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosisE F Stange, S P L Travis, S Vermeire, et al.
Gut|September 10, 2005
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohortF L Wolters, M G Russel, J Sijbrandij, et al.
Digestion|June 30, 2007
Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up studyK H Katsanos, S Vermeire, D K Christodoulou, et al.
Pageof 14